agilon health Names Diana McKenzie to Board of Directors
Agilon Health (NYSE: AGL) has appointed Diana McKenzie as an independent board director, effective immediately. McKenzie brings over 30 years of leadership experience in healthcare and technology, previously serving as CIO at Workday and holding roles at Amgen and Eli Lilly. Her expertise in digital transformation and risk management is expected to enhance Agilon's value-based care model, aiming to empower primary care physicians in improving patient outcomes and reducing costs. The board believes her insights will drive the company’s future growth.
- Diana McKenzie brings over 30 years of experience in healthcare and technology.
- Her appointment is expected to enhance Agilon's value-based care model.
- McKenzie’s expertise in digital transformation and risk management will be valuable.
- Concerns may arise regarding continuity in leadership due to the addition of a new board member.
“With the addition of Diana to agilon’s board of directors we are gaining a tenured executive with extensive leadership and health technology expertise, which will help to propel the company’s future growth,” said
“Diana is a pioneer in our industry with significant digital, risk management, and cybersecurity leadership experience,” said
“agilon health is charging into the next frontier of health care, which is why I am so excited to join the board,” said
McKenzie’s career has been focused on how companies can best utilize technology and data to drive business growth.
McKenzie most recently served as the first-ever Chief Information Officer for Workday, Inc., a cloud-based financial and human capital management software company, from 2016 to 2019. In that role, she laid a foundation for what a professional technology organization should do in a company and significantly enhanced Workday’s cybersecurity function.
Prior, McKenzie worked at Amgen, first as Executive Director, Information Systems and later as Chief Information Officer. There, she worked to reinsert innovation into all core functions across the company, including switching Amgen to
McKenzie currently serves on the boards of MetLife, Vertex Pharmaceuticals, and
About agilon health
agilon health is the trusted partner empowering physicians to transform health care in our communities. Through our partnerships and purpose-built platform, agilon is accelerating at scale how physician groups transition to a value-based Total Care Model for senior patients. agilon provides the technology, people, capital, process, and access to a peer network of 2,200+ PCPs that allow physician groups to maintain their independence and focus on the total health of their most vulnerable patients. Together, agilon and its physician partners are creating the healthcare system we need – one built on the value of care, not the volume of fees. The result: healthier communities and empowered doctors. agilon is the trusted partner in 25 diverse communities and is here to help more of our nation's leading physician groups and health systems have a sustained, thriving future. For more information about agilon health, visit www.agilonhealth.com and connect with us on Twitter, Instagram, LinkedIn and YouTube.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230222005125/en/
Investor Contact
Vice President, Investor Relations
investors@agilonhealth.com
Media Contact
Director, Communications & Public Affairs
media@agilonhealth.com
Source: agilon health inc.
FAQ
What is the significance of Diana McKenzie joining Agilon Health's board?
What role did Diana McKenzie hold before joining Agilon Health?
How might Diana McKenzie’s appointment impact Agilon Health's stock performance?